Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Observational, Cross-sectional Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients in Selected Areas of Gauteng and Eastern Cape

NCT01359800 is registered in ClinicalTrials.gov with Barbara Ensoli, MD as lead sponsor.

NCT NCT01359800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01359800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Observational, Cross-sectional Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients in Selected Areas of Gauteng and Eastern Cape
Lead sponsor
Barbara Ensoli, MD
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
July 31, 2013
Enrollment
531 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection